𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B

✍ Scribed by Giovanna Fattovich; Giuliano Giustina; Alfredo Alberti; Maria Guido; Patrizia Pontisso; Susanna Favarato; Luisa Benvegnù; Arturo Ruol

Book ID
118566270
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
470 KB
Volume
21
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of thymosin α1 in patients with
Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T

A randomized controlled trial of lymphob
A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg
✍ Giovanna Fattovich; Patrizia Farci; Massimo Rugge; Lucio Brollo; Antonella Manda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi

Prospective, randomized controlled trial
Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B
✍ Mercedes Ruiz-Moreno; Maria José Rua; Josefina Molina; Gloria Moraleda; Alberto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Thirty-six children with chronic hepatitis B were entered into a randomized controlled trial of recombinant human interferon-a. All patients had hepatitis B virus DNA and increased levels of aminotransferases in serum for at least 1 yr. Twelve children received 10 MU of interferon-a 2b/m2 body surfa